Canopy Biosciences launches the first of a series of targeted assay kits for ChipCytometry

By | December 8, 2021
Canopy Biosciences, a Bruker Company, today announced the launch of a first in a series of assay kits for ChipCytometry, a quantitative, high dynamic range and high-resolution multiplexing technology for spatial proteomics.